CorMedix Inc. (CRMD) Cash Flow Statement
CorMedix Inc. (CRMD) generated $253.9M of operating cash flow over the twelve months to 2026-06-30, spent $3.5M on capital expenditure and had free cash flow of $250.4M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CRMDCorMedix Inc.Follow CRMD — free
—
Price chart with a free account
- Market cap
- 611.9M
- P/E TTM
- 3.8
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -3.6 | -6.3 | -12.5 | -22.3 | -28.6 | -23.7 | -15.1 | -22.0 | -21.2 | -24.4 | -50.6 | 175.0 | 253.9 | |
| Capital expenditure | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.0 | 0.0 | 0.1 | 1.4 | 0.2 | 0.1 | 2.3 | -3.5 | |
| Free cash flow | -3.7 | -6.3 | -12.5 | -22.3 | -28.7 | -23.7 | -15.1 | -22.1 | -22.6 | -24.6 | -50.7 | 172.8 | 250.4 | |
| Stock-based compensation | 1.3 | 2.2 | 3.2 | 1.3 | 1.7 | 1.1 | 2.4 | 2.5 | 5.0 | 4.1 | 6.1 | 13.8 | — |
USD millions · SEC XBRL
CorMedix Inc. — questions
- What is CorMedix Inc.'s operating cash flow?
- $253.9M over the twelve months to 2026-06-30.
- How much does CorMedix Inc. spend on capital expenditure?
- $3.5M over the twelve months to 2026-06-30.
- What is CorMedix Inc.'s free cash flow?
- $250.4M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from CorMedix Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.